We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00033007
Recruitment Status : Completed
First Posted : April 8, 2002
Last Update Posted : January 12, 2017
Sponsor:
Information provided by:

April 5, 2002
April 8, 2002
January 12, 2017
April 2001
February 2003   (Final data collection date for primary outcome measure)
  • ASI
  • Cocaine use
  • AIDS risk behavior
  • AIDS risk behavior
  • ASI
  • Cocaine use
Complete list of historical versions of study NCT00033007 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.
The purpose of the proposed research is to implement and systematically evaluate, in community treatment settings, motivational incentive procedures that have been well researched and have proven efficacious in a variety of treatment research clinics.
Interventional
Phase 3
Allocation: Randomized
Primary Purpose: Treatment
Substance-Related Disorders
Behavioral: Behavior Therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
440
February 2003
February 2003   (Final data collection date for primary outcome measure)

Inclusion Criterea:

  • New intake to a drug-free CTP
  • Evidence of cocaine or methamphetamine use, any reported use in past 2 weeks or positive urine screen at study intake. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment

Exclusion Criteria:

  • Unable to give informed consent (fails simple consent quiz)
  • Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous problems with gambling?
Sexes Eligible for Study: All
up to 99 Years   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00033007
NIDA-CTN-0006-1
Yes
Not Provided
Not Provided
Maxine Stitzer, Ph.D., Johns Hopkins Bayview Medical Center
Johns Hopkins University
Not Provided
Principal Investigator: Maxine Stitzer, Ph.D. Johns Hopkins University
National Institute on Drug Abuse (NIDA)
April 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP